242 related articles for article (PubMed ID: 11853686)
1. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
J Lipid Res; 1999 Jul; 40(7):1317-27. PubMed ID: 10393217
[TBL] [Abstract][Full Text] [Related]
3. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Wilcox LJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
[TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
[TBL] [Abstract][Full Text] [Related]
5. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat.
Post SM; Zoeteweij JP; Bos MH; de Wit EC; Havinga R; Kuipers F; Princen HM
Hepatology; 1999 Aug; 30(2):491-500. PubMed ID: 10421659
[TBL] [Abstract][Full Text] [Related]
6. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.
Avramoglu RK; Cianflone K; Sniderman AD
J Lipid Res; 1995 Dec; 36(12):2513-28. PubMed ID: 8847478
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
Borradaile NM; de Dreu LE; Barrett PH; Huff MW
J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
[TBL] [Abstract][Full Text] [Related]
8. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells.
Furukawa S; Sakata N; Ginsberg HN; Dixon JL
J Biol Chem; 1992 Nov; 267(31):22630-8. PubMed ID: 1429611
[TBL] [Abstract][Full Text] [Related]
9. The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
Burnett JR; Telford DE; Barrett PH; Huff MW
Biochim Biophys Acta; 2005 Dec; 1738(1-3):10-8. PubMed ID: 16427354
[TBL] [Abstract][Full Text] [Related]
10. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and secretions of apolipoprotein B-containing lipoprotein and bile acids in HepG2.
Azuma Y; Kawasaki T; Ohno K; Seto J; Yamada T; Yamasaki M; Nobuhara Y
Jpn J Pharmacol; 1999 Feb; 79(2):151-8. PubMed ID: 10202850
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells.
Musanti R; Giorgini L; Lovisolo PP; Pirillo A; Chiari A; Ghiselli G
J Lipid Res; 1996 Jan; 37(1):1-14. PubMed ID: 8820097
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the ACAT inhibitor avasimibe (CI-1011).
Llaverías G; Laguna JC; Alegret M
Cardiovasc Drug Rev; 2003; 21(1):33-50. PubMed ID: 12595916
[TBL] [Abstract][Full Text] [Related]
13. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes.
Taghibiglou C; Rudy D; Van Iderstine SC; Aiton A; Cavallo D; Cheung R; Adeli K
J Lipid Res; 2000 Apr; 41(4):499-513. PubMed ID: 10744770
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
Graham A; Wood JL; Russell LJ
Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester.
Wu X; Sakata N; Lui E; Ginsberg HN
J Biol Chem; 1994 Apr; 269(16):12375-82. PubMed ID: 8163541
[TBL] [Abstract][Full Text] [Related]
16. Transmembrane lipid transfer is crucial for providing neutral lipids during very low density lipoprotein assembly in endoplasmic reticulum.
Higashi Y; Itabe H; Fukase H; Mori M; Fujimoto Y; Takano T
J Biol Chem; 2003 Jun; 278(24):21450-8. PubMed ID: 12670935
[TBL] [Abstract][Full Text] [Related]
17. Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles.
Hu L; Li J; Cai H; Yao W; Xiao J; Li YP; Qiu X; Xia H; Peng T
Antiviral Res; 2017 Dec; 148():5-14. PubMed ID: 29074218
[TBL] [Abstract][Full Text] [Related]
18. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
Cianflone KM; Yasruel Z; Rodriguez MA; Vas D; Sniderman AD
J Lipid Res; 1990 Nov; 31(11):2045-55. PubMed ID: 1964953
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of acyl-coenzyme a: cholesterol acyltransferase.
Miyazaki A; Kanome T; Watanabe T
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):463-9. PubMed ID: 16503866
[TBL] [Abstract][Full Text] [Related]
20. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
Tardif JC; Grégoire J; L'Allier PL; Anderson TJ; Bertrand O; Reeves F; Title LM; Alfonso F; Schampaert E; Hassan A; McLain R; Pressler ML; Ibrahim R; Lespérance J; Blue J; Heinonen T; Rodés-Cabau J;
Circulation; 2004 Nov; 110(21):3372-7. PubMed ID: 15533865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]